Menu
Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 2
Can macular translocation be a satisfactory management of subfoveal choroidal neovascular membrane?
Authors Bereczki Á, Bíró Zsolt
Published 6 June 2008 Volume 2008:2(2) Pages 447—450
Árpád Bereczki1, Zsolt Bíró2
1“Petz Aladár” County Teaching Hospital, Department of Ophthalmology, Győr, Hungary; 2St Imre Hospital, Department of Ophthalmology, Budapest, Hungary
Purpose: To report histopathological observations regarding one of our macular translocation cases.
Methods: We have performed macular translocation with 360 degree retinotomy since 1997, and limited macular translocation with or without subretinal membrane removal since 2002. One of our patients died on the fifth postoperative day, so extensive histological examination of the removed neovascular membrane and entire globe was performed.
Results: We found that pigment epithelium remained attached to the neurosensory retina during retinal separation, in which case the rotated fovea will be relocated in a partially devoided pigment epithelial zone. In addition, even after complete surgical removal of the membrane during macular translocation, large membrane remnants are still detectable by histological examination.
Conclusion: In our opinion, macular translocation is not a satisfactory management of subfoveal neovascular membranes, because of changes in the pigment epithelium during surgery, and large subretinal neovascular membrane remnants.
Keywords: age-related macular degeneration (AMD), choroidal neovascularization (CNV), choroidal subretinal membrane, macular translocation, histology
© 2008 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.